The Limited Times

Now you can see non-English news...

Remdesivir, used against Covid-19, has already earned Gilead nearly $ 900 million

2020-10-28T21:47:53.610Z

Thanks to the sales of this product, the group saw its quarterly turnover increase in total by 17% to 6.58 billion dollars.



The antiviral drug remdesivir, used for hospital patients with Covid-19, has already reported to its manufacturer Gilead Sciences nearly $ 900 million in the third quarter, the pharmaceutical company announced on Wednesday.

Read also: The United States fully authorizes the antiviral remdesivir against Covid-19

Thanks to sales of this product, initially developed in vain against Ebola hemorrhagic fever, the group saw its quarterly turnover increase in total by 17% to 6.58 billion dollars.

Source: lefigaro

All business articles on 2020-10-28

You may like

News/Politics 2020-11-21T09:41:38.276Z
Life/Entertain 2020-11-21T09:44:49.627Z

Trends 24h

Latest

© Communities 2019 - Privacy